CGC logo

Canopy Growth (CGC)

Profile

Full Name

Canopy Growth Corporation

Ticker Symbol

CGC

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Canada

IPO

April 7, 2014

Indexes

Not included

Website

http://www.canopygrowth.com

Employees

1029

Key Details

Price

$1.18(+16.83%)

Market cap

$184.32M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$220.24M(-12.63% YoY)

Annual EPS

-$6.52(+87.82% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.18
CGC price is $1.18

30-Day Relative Volume

2.46
CGC 30-day relative volume is 2.46

Price Performance

Price Most recent change

+16.83%
CGC price was up +16.83% on Apr 16, 2025

Price YTD change

-56.93%
CGC price is down -56.93% since January 1st

Price 1-year change

-82.39%
CGC price is down -82.39% year-on-year

Price 3-year change

-98.27%
CGC price is down -98.27% over the past 3 years

Price Range

Price All-time high

$592.50
CGC price is currently -99.80% below its historical high of $592.50

Price 3-year low

$0.77
CGC price is currently +53.25% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$184.32M
CGC market capitalization is $184.32 million

Market cap 3-year change

-93.15%
CGC market capitalization is down -93.15% over the past 3 years

Market cap All-time high

$19.66B
CGC market capitalization is currently -99.06% below its historical high of $19.66 billion

Market cap sector rank

56.33%
CGC market capitalization is higher than 56.33% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+71.43%
CGC shares outstanding is up +71.43% year-on-year

Shares Outstanding 3-Year Change

+296.03%
CGC shares outstanding is up +296.03% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.08
CGC beta is 1.08

200-day SMA

$3.79
CGC price is currently -68.89% below its 200-day simple moving average

50-day SMA

$1.32
CGC price is currently -10.43% below its 50-day simple moving average

RSI

55.02
CGC 14-day relative strength index is 55.02

Volume

2.46
CGC 30-day relative volume is 2.46

ATR

$0.12
CGC average true range is $0.12

10-day Historical Volatility

146.06%
CGC 10-day historical volatility is 146.06%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$220.24M
CGC annual revenue is $220.24 million

Revenue Analysts estimate

$276.19M
CGC annual revenue is currently -20.26% lower than the consensus analysts' forecast

Revenue 1-year change

-12.63%
CGC annual revenue is down -12.63% year-on-year

Revenue Sector rank

65.47%
CGC annual revenue is higher than 65.47% of companies in Healthcare sector

EPS

EPS

-$6.52
CGC annual earnings per share is -$6.52

EPS Analysts estimate

-$3.40
CGC annual earnings per share is currently +91.62% higher than the consensus analysts' forecast

EPS 1-year change

+87.82%
CGC annual earnings per share is up +87.82% year-on-year

EPS Sector rank

15.82%
CGC annual earnings per share is higher than 15.82% of companies in Healthcare sector

Profit

Gross profit

$59.95M
CGC annual gross profit is $59.95 million

Gross margin

27.22%
CGC annual gross profit margin is 27.22%

Operating profit

-$94.84M
CGC annual operating income is -$94.84 million

Operating margin

-43.06%
CGC annual operating profit margin is -43.06%

Net income

-$487.16M
CGC annual net profit is -$487.16 million

Net margin

-221.19%
CGC annual net profit margin is -221.19%

Expenses

Total expenses

$315.09M
CGC annual total expenses is $315.09 million

Operating expenses

$154.79M
CGC annual total operating expenses is $154.79 million

Cost of goods sold

$160.29M
CGC annual cost of goods sold is $160.29 million

Selling, general & administrative expenses

$130.43M
CGC annual SGA is $130.43 million

Depreciation and amortization

$39.41M
CGC annual depreciation & amortization is $39.41 million

Interest expense

$78.09M
CGC annual interest expense is $78.09 million

Income tax

$9.14M
CGC annual income tax is $9.14 million

EBIT & EBITDA

EBIT

-$271.28M
CGC annual earnings before interest & taxes is -$271.28 million

EBITDA

-$231.87M
CGC annual EBITDA is -$231.87 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$962.35M
CGC annual total assets is $962.35 million

Non current assets

$687.65M
CGC annual long term assets is $687.65 million

Current assets

$274.70M
CGC annual total current assets is $274.70 million

Cash and cash equivalents

$126.04M
CGC annual cash & cash equivalents is $126.04 million

Accounts receivable

$33.26M
CGC annual accounts receivable is $33.26 million

Inventory

$57.20M
CGC annual inventory is $57.20 million

Liabilities

Total liabilities

$591.94M
CGC annual total liabilities is $591.94 million

Long term liabilities

$418.23M
CGC annual total long term liabilities is $418.23 million

Current liabilities

$173.71M
CGC annual total current liabilities is $173.71 million

Accounts payable

$21.22M
CGC annual accounts payable is $21.22 million

Debt

Total debt

$494.37M
CGC annual total debt is $494.37 million

Total debt 1-year change

-52.7%
CGC annual total debt is down -52.7% year-on-year

Long term debt

$406.22M
CGC annual long term debt is $406.22 million

Short term debt

$88.15M
CGC annual short term debt is $88.15 million

Equity & Capital

Shareholders equity

$370.31M
CGC annual stockholders equity is $370.31 million

Book value

$370.31M
CGC annual book value is $370.31 million

Retained earnings

-$7.65B
CGC annual retained earnings is -$7.65 billion

Working capital

$101.00M
CGC annual working capital is $101.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$208.98M
CGC annual cash flow from operations is -$208.98 million

Cash from operations 1-year change

+50.45%
CGC annual cash flow from operations is up +50.45% year-on-year

Cash from investing

$179.06M
CGC annual cash flow from investing activities is $179.06 million

Cash from investing 1-year change

-45.37%
CGC annual cash flow from investing activities is down -45.37% year-on-year

Cash from financing

-$344.70M
CGC annual cash flow from financing activities is -$344.70 million

Cash from financing 1-year change

-2213.97%
CGC annual cash flow from financing activities is down -2213.97% year-on-year

CAPEX

CAPEX

$2.96M
CGC annual capital expenditures is $2.96 million

CAPEX 1-year change

-62.53%
CGC annual capital expenditures is down -62.53% year-on-year

Free Cash Flow

Free cash flow

-$211.94M
CGC annual free cash flow is -$211.94 million

Free cash flow 1-year change

+50.67%
CGC annual free cash flow is up +50.67% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

27.22%
CGC annual gross profit margin is 27.22%

Operating margin

-43.06%
CGC annual operating profit margin is -43.06%

Net margin

-221.19%
CGC annual net profit margin is -221.19%

ROA & ROE

ROA

-35.22%
CGC annual return on assets is -35.22%

ROE

-104.51%
CGC annual return on equity is -104.51%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CGC price to earnings ratio value is unknown

PE ratio Sector rank

-
CGC price to earnings ratio is unknown

PB Ratio

PB ratio

0.45
CGC price to book ratio is 0.45

PB ratio Sector rank

28.56%
CGC price to book ratio is higher than 28.56% of companies in Healthcare sector

PS Ratio

PS ratio

0.91
CGC price to sales ratio is 0.91

PS ratio Sector rank

26.28%
CGC price to sales ratio is higher than 26.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$412.70M
CGC enterprise value is $412.70 million

Enterprise value Sector rank

67.16%
CGC enterprise value is higher than 67.16% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.63
CGC EV/EBITDA is -1.63

EV/EBITDA Sector rank

35.34%
CGC EV/EBITDA is higher than 35.34% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.58
CGC annual current ratio is 1.58

Quick ratio

1.25
CGC annual quick ratio is 1.25

Leverage

Debt to equity

1.19
CGC annual debt to equity ratio is 1.19

Interest coverage ratio

-3.47
CGC annual interest coverage ratio is -3.47

Risk & Stability

Piotroski F-Score

4
CGC piotroski f-score is 4

Altman Z-Score

-11.51
CGC altman z-score is -11.51

Analyst ratings

Recent major analysts updates

Mar 27, 25 Zuanic & Associates
Neutral
Jul 9, 24 Piper Sandler
Underweight
Sep 15, 23 B of A Securities
Underperform
Jun 12, 23 CIBC
Underperformer
May 2, 23 Piper Sandler
Underweight
Feb 17, 23 Cantor Fitzgerald
Neutral
Nov 7, 22 Cantor Fitzgerald
Neutral
Nov 2, 22 Bernstein
Underperform
Oct 26, 22 Cantor Fitzgerald
Neutral
Sep 30, 22 Barclays
Underweight

Institutional Ownership

Similar stocks

MDWD logo
MediWound (MDWD)
INGN logo
Inogen (INGN)
CRDF logo
Cardiff Oncology (CRDF)
TVGN logo
Tevogen Bio Holdings (TVGN)
SOPH logo
SOPHiA GENETICS SA (SOPH)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
HITI logo
High Tide (HITI)
GOSS logo
Gossamer Bio (GOSS)
ELDN logo
Eledon Pharmaceuticals (ELDN)
  • What is the ticker symbol for Canopy Growth?
  • Does Canopy Growth pay dividends?
  • What sector is Canopy Growth in?
  • What industry is Canopy Growth in?
  • What country is Canopy Growth based in?
  • When did Canopy Growth go public?
  • Is Canopy Growth in the S&P 500?
  • Is Canopy Growth in the NASDAQ 100?
  • Is Canopy Growth in the Dow Jones?
  • When was Canopy Growth's last earnings report?
  • When does Canopy Growth report earnings?

What is the ticker symbol for Canopy Growth?

The ticker symbol for Canopy Growth is NASDAQ:CGC

Does Canopy Growth pay dividends?

No, Canopy Growth does not pay dividends

What sector is Canopy Growth in?

Canopy Growth is in the Healthcare sector

What industry is Canopy Growth in?

Canopy Growth is in the Drug Manufacturers - Specialty & Generic industry

What country is Canopy Growth based in?

Canopy Growth is headquartered in Canada

When did Canopy Growth go public?

Canopy Growth's initial public offering (IPO) was on April 7, 2014

Is Canopy Growth in the S&P 500?

No, Canopy Growth is not included in the S&P 500 index

Is Canopy Growth in the NASDAQ 100?

No, Canopy Growth is not included in the NASDAQ 100 index

Is Canopy Growth in the Dow Jones?

No, Canopy Growth is not included in the Dow Jones index

When was Canopy Growth's last earnings report?

Canopy Growth's most recent earnings report was on Feb 7, 2025

When does Canopy Growth report earnings?

The next expected earnings date for Canopy Growth is May 30, 2025
On this page